Understanding heart damage from cancer treatments
Managing Cardiac Toxicities of Cancer Therapy
This study is looking at how inflammation in the heart can lead to heart problems for people who have had chemotherapy, and it aims to find ways to protect the heart and improve care for cancer survivors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10991661 on NIH RePORTER |
What this research studies
This research investigates how inflammation in the heart contributes to heart failure caused by chemotherapy. It focuses on the role of inflammasomes, which are protein complexes that can trigger inflammation, in the context of cardiac injury from cancer therapies. By studying different types of heart cells and their responses to stress signals, the research aims to identify mechanisms that lead to heart damage and explore potential protective strategies. The findings could help develop treatments to mitigate heart-related side effects in cancer survivors.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer survivors who have experienced heart issues related to their treatment.
Not a fit: Patients who have not undergone cancer therapy or do not have any cardiac complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing heart damage in patients undergoing cancer treatment.
How similar studies have performed: Previous studies have shown success in understanding the role of inflammasomes in heart injury, indicating that this approach has a solid foundation.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Salloum, Fadi N — Virginia Commonwealth University
- Study coordinator: Salloum, Fadi N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.